购物车
全部删除
您的购物车当前为空
别名 Z-Phe-chloromethylketone, ZLPhe chloromethyl ketone, Z L Phe chloromethyl ketone, NSC-251810
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.

SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 250 mg | ¥ 938 | 35日内发货 | |
| 500 mg | ¥ 1,720 | 35日内发货 | |
| 1 g | ¥ 2,330 | 35日内发货 |
SL-01 相关产品
| 产品描述 | SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine. |
| 别名 | Z-Phe-chloromethylketone, ZLPhe chloromethyl ketone, Z L Phe chloromethyl ketone, NSC-251810 |
| 分子量 | 331.79 |
| 分子式 | C18H18ClNO3 |
| CAS No. | 26049-94-5 |
| 密度 | 1.1630 g/cm3 (Estimated) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: Soluble |
评论内容